Nurse Practitioner, Family · Tulsa, OK
NPI
1588148571
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
4750 S Garnett Rd Ste C
Tulsa, OK, 74146
Phone (539) 812-2106
Groups this clinician bills Medicare through
Medicare paid, 2024
$958K
92,054 services
Medicare patients, 2024
182
Average age 69
Drug cost, 2024
$7.4M
3,455 prescriptions
Company payments, 2025
$29K
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeremy M Morgan was code J3262 (injection, tocilizumab, 1 mg), 35,750 times for 12 patients. In total Jeremy M Morgan billed 92,054 services in 57 codes, and Medicare paid $958K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 35,750 | 12 | $4.70 | $168K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 8,176 | 18 | $24.32 | $199K |
| J0897 Injection, denosumab, 1 mg | Office | 2,462 | 27 | $20.66 | $51K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 2,406 | 13 | $0.23 | $551 |
| 96413 Chemotherapy Administration | Office | 422 | 53 | $71.26 | $30K |
| 99214 Office E&M - Established | Office | 360 | 144 | $71.92 | $26K |
| 96375 Injection Administration | Office | 338 | 19 | $8.54 | $2,887 |
| 85025 Blood Count | Office | 315 | 143 | $7.50 | $2,363 |
| 85652 Clinical Chemistry | Office | 313 | 144 | $2.61 | $818 |
| 86140 Clinical Chemistry | Office | 305 | 141 | $5.01 | $1,527 |
| 96415 Chemotherapy Administration | Office | 301 | 22 | $16.14 | $4,858 |
| 80053 Clinical Chemistry | Office | 299 | 140 | $10.19 | $3,047 |
| 36415 Venipuncture Blood Collection | Office | 200 | 125 | $8.57 | $1,714 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 170 | 17 | $0.62 | $105 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 161 | 30 | $0.51 | $82.47 |
By year: 2022 $746K for 47,869 services; 2023 $1.4M for 105,389 services; 2024 $958K for 92,054 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 315 | 143 | $7.50 | $2,363 |
| 85652 Clinical Chemistry | 313 | 144 | $2.61 | $818 |
| 86140 Clinical Chemistry | 305 | 141 | $5.01 | $1,527 |
| 80053 Clinical Chemistry | 299 | 140 | $10.19 | $3,047 |
| 36415 Venipuncture Blood Collection | 200 | 125 | $8.57 | $1,714 |
| 84550 Clinical Chemistry | 54 | 37 | $4.35 | $235 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeremy M Morgan prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 390 prescriptions and refills. In total Jeremy M Morgan wrote 3,455 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 390 | 779 | 110 | $14K |
| Prednisone Generic | 362 | 463 | 112 | $1,481 |
| Leflunomide Generic | 306 | 524 | 80 | $15K |
| Allopurinol Generic | 236 | 416 | 45 | $1,688 |
| Methotrexate Methotrexate Sodium | 170 | 332 | 61 | $5,256 |
| Celecoxib Generic | 113 | 199 | 30 | $2,275 |
| Gabapentin Generic | 102 | 160 | 22 | $1,453 |
| Rinvoq Upadacitinib | 101 | 103 | 11 | $667K |
| Meloxicam Generic | 98 | 175 | 24 | $269 |
| Cyclobenzaprine Hcl Generic | 83 | 123 | 20 | $911 |
| Colchicine Generic | 80 | 109 | 19 | $9,517 |
| Potassium Chloride Generic | 77 | 141 | 18 | $557 |
| Azathioprine Generic | 74 | 128 | 19 | $2,342 |
| Taltz Autoinjector Ixekizumab | 67 | 67 | Under 11 | $454K |
| Sulfasalazine Generic | 62 | 92 | 14 | $1,277 |
Brand drugs: 722 claims; generic drugs: 2,720 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeremy M Morgan $29K ($29K in general payments such as food, travel and fees) from 25 companies. The largest payer was UCB, Inc. with $18K.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 77 | $18K |
| Kyowa Kirin, Inc. 4151.T | 14 | $3,168 |
| Janssen Biotech, Inc. JNJ | 17 | $3,130 |
| Amgen Inc. AMGN | 29 | $1,000 |
| Alexion Pharmaceuticals, Inc. AZN | 3 | $583 |
| AstraZeneca Pharmaceuticals LP AZN | 18 | $543 |
| Abbvie Inc. ABBV | 18 | $374 |
| ANI Pharmaceuticals, Inc. ANIP | 15 | $344 |
| E.R. Squibb & Sons, L.L.C. BMY | 7 | $326 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $254 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.